Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022.

MLA

Hoeve, Christina E., et al. “Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022.” The Journal of Infectious Diseases, vol. 228, no. 4, Aug. 2023, pp. 431–38. EBSCOhost, https://doi.org/10.1093/infdis/jiad110.

APA

Hoeve, C. E., de Gier, B., Huiberts, A. J., de Melker, H. E., Hahné, S. J. M., van den Hof, S., & Knol, M. J. (2023). Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022. The Journal of Infectious Diseases, 228(4), 431–438. https://doi.org/10.1093/infdis/jiad110

Chicago

Hoeve, Christina E, Brechje de Gier, Anne J Huiberts, Hester E de Melker, Susan J M Hahné, Susan van den Hof, and Mirjam J Knol. 2023. “Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022.” The Journal of Infectious Diseases 228 (4): 431–38. doi:10.1093/infdis/jiad110.